This study will look at the way professors and students feel about primary source materials in the Jewish Studies undergraduate classroom. Examples of primary sources include diaries, maps, photos, and more.
Are you diagnosed with chronic graft versus host disease (cGVHD)? If so, you might be able to take part in a study to evaluate the safety and efficacy of belumosudil in combination with corticosteroids.
Do you have type one diabetes? Have you experienced low blood sugar? If you have T1DM, are using insulin, and have a CGM, you may be able to participate in a research study to see if an oral pill used with your current medications may help to lower the risk of hypoglycemia. Compensation provided.
Are you premenopausal and have been diagnosed with ER-positive, HER2-negative breast cancer and had surgery for your breast cancer? If so, you may be able to take part in a research study evaluating the addition of chemotherapy given after breast surgery with ovarian suppression and endocrine therapy versus ovarian suppression and endocrine therapy alone.
The survey and its findings will help us understand attitudes around cancer family history and genetic testing among Black people. This information will be used to develop an educational curriculum to strive towards health equity for Black people diagnosed with or at higher risk of cancer and get Black people the best cancer care.
In this pilot study, we want to find out more about the activities and health of patients after a heart attack or stent procedure.
The purpose of this research study is to understand the digital tools used by people in recovery for alcohol use disorders. In this study, we will do interviews with participants. These interviews will help us to get an understanding of the efforts to maintain their sobriety and any digital tools that they currently use.
Do you use a THC vaping device? Help us learn more about what it does to your lungs. Compensation will be provided.
This is a study for people with chronic kidney disease and type 1 diabetes. In this study, we want to learn more about the effectiveness and safety of a kidney drug called finerenone compared to a placebo.
We are studying different types of treatments that modify the activity of immune cells involved in type 1 diabetes, also known as autoimmune diabetes.
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
